Abstract
Objective
To investigate the antibacterial activity of henna (Lawsonia inermis Linn) obtained from different regions of Oman against a wide array of micro-organisms.
Methods
Fresh henna samples were obtained from different regions of Oman as leaves and seeds. 100 g fresh and dry leaves and 50 g of fresh and dry seeds were separately soaked in 500 mL of ethanol for three days, respectively, with frequent agitation. The mixture was filtered, and the crude extract was collected. The crude extract was then heated, at 48 °C in a water bath to evaporate its liquid content. The dry crude henna extract was then tested for its antibacterial activity using well-diffusion antibiotic susceptibility technique. Henna extracts were investigated for their antibacterial activity at different concentrations against a wide array of different micro-organisms including a laboratory standard bacterial strain of Pseudomonas aeruginosa (NCTC 10662) (P. aeruginosa) and eleven fresh clinical isolates of P. aeruginosa obtained from patients attending the Sultan Qaboos University Hospital (SQUH). 2-Hydroxy-p-Nathoqinone-Tech (2-HPNT, MW=174.16, C10H6O3) was included as control (at 50% concentration) along with the henna samples tested.
Results
Henna samples demonstrated antibacterial activity against all isolates but the highest susceptibility was against P. aeruginosa with henna samples obtained from Al-sharqyia region.
Conclusions
Omani henna from Al-sharqyia region demonstrates high in vitro anti-P. aeruginosa activity compared with many henna samples from different regions of Oman.
Keywords: Pseudomonas aeruginosa, Lawsonia inermis Linn, Henna, Antibacterial activity, Oman, Antibiotic susceptibility, Micro-organism, Bacterial strain, Clinical isolate, Crude extract
1. Introduction
Pseudomonas is a gram negative rod micro-organism that belongs to the family Pseudomonadaceae. These pathogens are widespread in nature, inhabiting soil, water, plants, animals and humans. Pseudomonas aeruginosa (P. aeruginosa) is an important cause of infection in patients with compromised host defence mechanisms. It is the most common pathogen isolated from patients hospitalized longer than a week and is a common cause of nosocomial infections such as pneumonia, urinary tract infections and bacteremia[1]. Bacteremic pneumonia occurs in patients with neutropenia following chemotherapy and in patients with acquired immunodeficiency syndrome (AIDS)[1]. Pseudomonal bacteremia occurs in association with malignancy, chemotherapy, AIDS, burn wound sepsis, and diabetes[1]. Predisposing conditions include placement of intravenous lines, severe burns, urinary tract catheterization, surgery, trauma, and premature birth[1]. Infections with P. aeruginosa are complicated and can be life threatening[1]. The bacterium is resistant to many antibiotics and disinfectants, which makes it a difficult pathogen to treat.
Traditional healers have long used plants to prevent or cure infectious diseases. Almost 50% of current pharmaceuticals are derived from the plant kingdom. Plants are rich in a wide variety of secondary metabolites polyphenols, such as tannins, terpenoids, alkaloids, and flavonoids, which have been demonstrated to have in vitro antimicrobial properties[2]–[5].
Henna [Lawsonia inermis (L. inermis) Linn] is known to have medicinal properties[4],[6],[7]. Different species of henna are present and grown in Oman, at the south-eastern tip of the Arabian Peninsula. Omani henna is prevalent in Eastern and central areas of Oman.
The antimicrobial[8] and fungicidal[9],[10] effect of henna has long been known and more recent studies in our laboratories confirmed previous observations[4]. In this present study we investigated the effect of the local Omani henna on several bacteria including P. aeruginosa and other clinical laboratory isolates. This is one part of a wider project in which we envisage to test henna on a wider variety of bacteria, viruses and fungi.
2. Materials and methods
2.1. Plant materials
The plants (as fresh leaves and seeds) were harvested from different localities (Nakhal, Salalah, Musandam, Nizwa, Khabora, Wadi and Bani-Awf) of Oman in July 2008 and identified based on ethnomedical data and interview with local communities in parallel with the Pharmacognosy Department, Faculty of Pharmacy, Sultan Qaboos University. The leaves and seeds were collected and washed thoroughly with water and air dried under shade and ground using a pestle and mortar.
2.2. Extraction of plant material
The air-dried materials of leaves (100 g) and seeds (50 g) were ground to a fine powder with a pestle and mortar. 100 g fresh and dry leaves and 50 g of fresh and dry seeds were extracted respectively, with 50% ethanol (600 mL) for three days, with frequent agitation. The ethanol extract was filtered through Whatmann No. 1 (Whatmann International Ltd, Maidstone, UK) paper and the filtrates were collected and heated in water-bath at 48 °C to evaporate its liquid content. The residue was dried further over night in an oven at 37 °C. The extracts were preserved at -20 °C until use.
2.3. Test organisms
A wide array of different micro-organisms (Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, P. aeruginosa, Bacillus spp, Klesiella pneumoniae, Salmonella spp, Shigella sonnei, Citrobacter frewndii, Vibrio cholerae, Neisseria meningitides, Haemophilus influenzae, Aeromonas hydrophila, MRSA, Micrococcus spp, Corynebacterium diphtheriae, Candida albicans, Cryptococcus neoformans, Streptococcus pyogenes, Streptococcus pneumoniae, Bacteriodes fragilis, Clostridium perfringens), were initially screened for their susceptibility to the henna extracts at 50% concentration using the well diffusion method. P. aeruginosa (NCTC 10662), was used as the standard organism. This strain is used routinely for the antibiotic susceptibility tests of all Pseudomonas isolates in Sultan Qaboos University Hospital (SQUH). In addition, eleven clinical strains of P. aeruginosa isolated from patients attending the SQUH were used, for investigating the antibacterial activity of the different Omani henna samples, in parallel with the standard organism.
2.4. Antimicrobial assay
The well-diffusion assay[11] was used to determine the antimicrobial activity of the investigated extracts. Nutrient agar (OXOID LTD, Basingstoke, Hampshire, England) was prepared by dissolving of 27 g in water. One colony of each organism was emulsified in 4 mL of distilled water, to give approximately 1.0×104 CFU/mL. This was subsequently used to swab agar plates of diagnostic sensitivity test (DST, Oxoid, England). Wells of 4 mm in diameter were made and 60 µL of each henna “crude extract” dilution at different concentrations (50%, 25%, 12.5%) was prepared using sterile distilled water and placed into each well with a chipped tip pipette. Each dilution was tested in triplicate. Plates were kept for 2 h in refrigerator to enable prediffusion of the extracts into the agar. Then, the plates were incubated overnight (18 h) at 37 °C. Ampicillin, gentamicin and amphotericin B were used as positive control. Negative controls were performed using 2-Hydroxy-p-Nathoqinone-Tech (2-HPNT, MW=174.16, C10H6O3) (at 50% concentration) along with the henna samples tested. At the end of the incubation period the antibacterial activity was evaluated by measuring the inhibition zones (diameter of inhibition zone plus diameter of the well).
3. Results
Most of the henna samples obtained from different parts of Oman demonstrated low to intermediate activity against a wide range of micro-organisms (Table 1). However, fresh leaves obtained from Al-sharqiya region had the highest anti-P. aeruginosa activity (Figure 1). The antibacterial activity was higher than the 2-HPNT control used (Figure 1). All the four samples obtained from Al-sharqiya region, and at 50% concentration, demonstrated high anti-P. aeruginosa activity compared with the control.
Table 1. Antimicrobial activity of henna obtained from different regions of Oman against an array of different micro-organisms (cm).
Micro-organism | Nakhal | Salalah | Musandam | Nizwa | Khabora | Wadi Bani-Awf | 2HPNT* |
Staphylococcus epidermidis | 2.0 | 2.5 | 2.8 | 2.5 | 2.2 | 3.5 | 3.5 |
Staphylococcus aureus | 2.0 | 2.1 | 2.0 | 1.9 | 2.5 | 4.0 | 4.0 |
Escherichia coli | 1.0 | 1.3 | 1.5 | 1.0 | 0.0 | 2.5 | 2.5 |
P. aeruginosa | 1.2 | 1.8 | 1.8 | 1.2 | 0.0 | 3.5 | 3.5 |
Bacillus spp. | 2.7 | 2.5 | 3.0 | 2.5 | 1.5 | 4.0 | 4.0 |
Klebsiella pneumoniae | 1.5 | 1.4 | 1.4 | 1.1 | 0.0 | 1.5 | 1.5 |
Salmonella spp. | 1.0 | 1.3 | 1.5 | 1.2 | 0.0 | 3.0 | 3.0 |
Shigella sonnei | 1.5 | 1.5 | 1.8 | 1.0 | 1.0 | 3.4 | 3.4 |
Citrobacter frewndii | 1.2 | 1.7 | 2.0 | 1.5 | 0.0 | 1.7 | 1.7 |
Vibrio cholerae | 2.5 | 3.0 | 2.8 | 3.0 | 1.5 | 3.5 | 3.5 |
Neisseria meningitidis | 2.0 | 2.5 | 2.2 | 2.6 | 1.0 | 2.6 | 2.6 |
Haemophilus influenzae | 1.7 | 2.2 | 2.0 | 2.5 | 1.9 | 3.0 | 3.0 |
Aeromonas hydrophila | 2.0 | 2.5 | 2.0 | 3.0 | 2.2 | 4.0 | 4.0 |
MRSA | 2.9 | 3.0 | 2.4 | 3.0 | 2.5 | 4.0 | 4.0 |
Micrococcus spp. | 2.0 | 2.5 | 2.4 | 3.0 | 1.5 | 3.5 | 3.5 |
Corynebacterium diphtheriae | 1.0 | 1.5 | 1.0 | 1.5 | 2.0 | 1.0 | 1.0 |
Candida albicans | 1.0 | 1.9 | 1.5 | 2.0 | 1.0 | 2.5 | 2.5 |
Cryptococcus neoformans | 1.5 | 2.5 | 2.5 | 2.9 | 1.5 | 2.9 | 2.9 |
Streptococcus pyogenes | 2.0 | 2.5 | 2.0 | 2.0 | 1.2 | 1.5 | 2.5 |
Streptococcus pneumoniae | 2.0 | 2.1 | 2.5 | 2.0 | 1.0 | 2.0 | 2.5 |
Bacteriodes fragilis | 1.0 | 2.0 | 1.5 | 1.5 | 1.2 | 2.0 | 4.0 |
Clostridium perfringens | 3.0 | 3.0 | 3.5 | 3.0 | 4.5 | 3.0 | 4.5 |
*Control: 2-HPNT (2-Hydroxy-p-Nathoqinone-Tech).
Figure 1. Antibacterial activity of henna fresh leaves against P. aeruginosa from Al-Sharquia region of Oman.
Control: 2-HPNT (2-Hydroxy-p-Nathoqinone-Tech.); H1-H4: Henna samples obtained from Jalan Bani Bu Ali, Sur, Badyia and Ibra, respectively. The samples H1-H4 were tested at 50% concentration. Zones of inhibition were measured in millimetres (mm) diameter and the average of three experiments was shown.
Fresh leaves, dry leaves, fresh seeds and dry seeds of the Omani henna samples demonstrated antibacterial activity against the standard strain of P. aeruginosa. Moreover, when using the clinical isolates of P. aeruginosa, the anti-P. aeruginosa activity was demonstrated up to 25% concentration of the fresh henna samples tested (Figure 2). All the anti-P. aeruginosa activity, at 50% concentration, was shown to be higher than the 2-HPNT control used. The antibacterial activity of the henna samples was still evident at 25% concentration, although the activity at this concentration was slightly lower than the control used (Figure 2). At concentration of 12.5 % the anti P.aeruginosa activity was not detected.
Figure 2. Anti-P. aeruginosa activity of Omani henna leaves and seeds at different concentrations.
2-HPNT: 2-Hydroxy-p-Nathoqinone-Tech, used as control. Zones of inhibition were measured in millimetres (mm) diameter and the average of three experiments was shown.
Dry leaves and fresh leaves demonstrated high activity against P. aeruginosa both at 50% and at 25% concentrations and the activities were higher than the tested control. Moreover, fresh seeds and dry seeds demonstrated higher activity compared with the control only at 50% concentration of the henna samples tested. At 25% concentration, the anti- P. aeruginosa activity was still evident but lower than the control (Figure 2).
4. Discussion
In this study we have shown that henna samples from different regions of Oman demonstrated antibacterial activity against a wide range of different bacterial strains with the highest antibacterial activity being demonstrated against P. aeruginosa organisms. P. aeruginosa is an opportunistic pathogen that rarely causes disease in healthy people. This bacterium has minimal nutritional requirements and can tolerate a wide variety of physical conditions. Pseudomonas species are both invasive and toxigenic[1]. The pathogenesis of P. aeruginosa infections is multifactorial and complex. P. aeruginosa is the fourth most commonly isolated nosocomial pathogen, accounting for approximately 10% of all hospital-acquired infections[12]. It is found on the skin of some healthy persons and has been isolated from the throat and stool of non-hospitalized patients[13]. The gastrointestinal carriage rates among hospitalized patients increases to 20% within 72 h of admission. Internationally, P. aeruginosa is common in immunocompromised patients with diabetes.
Although infections caused by P. aeruginosa are treatable and potentially curable, acute fulminant infections, such as bacteremic pneumonia, sepsis, burn wound infections, and meningitis, are associated with extremely high mortality rates[14]. Treatment of P. aeruginosa is usually through intravenous multiple antibiotic combinations, and unfortunately it does not always work. Pseudomonal infections are usually treated with a combination of anti-pseudomonal antibiotics such as cephalosporin, carbapenems, quinolones and aminoglycosides. However, with the emergence of antibiotic resistance, resulting in treatment failures, henna, among other natural products, may be a cheap alternative method for the treatment of pseudomonal infections.
Henna is widely used throughout Arabia including Oman. In addition to its use as a cosmetic, henna leaves are also used for fevers, as a local anesthetic[15], anti-inflammatory and for treating mouth ulcers[7]. The most striking antimicrobial effect of henna is demonstrated by the inhibitory activity against P. aeruginosa. It is interesting to note that antibacterial activity of some Omani henna was much higher than the tested control (2-HPNT). Our in vitro results indicate a possible important role for henna in the in vivo treatment of P. aeruginosa.
Although the fresh and dry seeds demonstrated antibacterial activity against P. aeruginosa, our fresh henna leaves demonstrated the highest anti-P. aeruginosa activity. Leaves of the Omani henna are strikingly most effective against the spectrum of bacterial isolates tested as compared with seeds. This is probably due to the inherent characteristics of the fully grown plants and the maturity of its chemically active constituents such as quinines. Such constituents would not have been established in seeds. Although fresh and dry seeds demonstrated antibacterial activities, these were less evident when compared with the effect of fresh and dry leaves. This may be attributed to the added presence of chlorophyll, which is one of the constituents of fresh leaves that are known to possess antimicrobial activity[4],[16],[17]. Henna leaves contain up to 5% by weight of the compound (2-hydroxy-1,4-naphthoquinone).
Quinones are present in henna[3]. These are aromatic rings with two ketone substitutions. They are ubiquitous in nature and are characteristically highly active. These compounds, being coloured, are responsible for the browning reaction in cut or injured fruits and vegetables and are an intermediate in the melanin synthesis pathway in human skin[18]. It is the presence of quinones in henna that gives the material its dyeing properties[3]. The switch between diphenol (or hydroquinone) and quinone occurs easily through oxidation and reduction reactions. The individual redox potential of the particular quinone-hydroquinone pair is very important in many biological systems. Hydroxilated amino acids may be made into quinones in the presence of suitable enzymes, such as a polyphenoloxidase[19]. In addition to providing a source of stable free radicals, quinones are known to complex irreversibly with nucleophilic amino acids in proteins[20], often leading to inactivation of the protein and loss of function. For that reason, the potential range of quinone antimicrobial effects is great. Portable targets in the microbial cell are surface-exposed adhesions, cell wall polypeptides, and membrane-bound enzymes. Quinones may also render substrates unavailable to the microorganism. In addition, they were shown to inhibit cell growth in culture[21].
We have concluded that some Omani henna possess high antibacterial activities against P. aeruginosa. Further work is required to further demonstrate this activity using different henna samples from different locations outside Oman. The possibility of using a cream or soaps incorporating henna active ingredients may be of great advantage for hygiene purposes for both physicians and patients in hospitals especially in intensive care units or infectious disease units where immuno-compromised patients are treated.
Acknowledgments
Funding for this project was provided by the Sultan Qaboos University (Grant No. IG/MED/ANAT/06/01). The authors would like to thank Ms. Zamzam Al-Bimani (Department of Microbiology and Immunology) for her technical assistance.
Footnotes
Foudation Project: Supported by Sultan Qaboos University (Grant No. IG/MED/ANAT/06/01).
Conflict of interest statement: We declare that we have no conflict of interest.
References
- 1.Veesenmeyer JL, Hauser AR, Lisboa T, Rello J. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med. 2009;37:1826–1827. doi: 10.1097/CCM.0b013e31819ff137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.González-Lamothe R, Mitchell G, Gattuso M, Moussa S, Malouin DF, Bouarab K. Plant antimicrobial agents and their effects on plant and human pathogens. Int J Mol Sci. 2009;10(8):3400–3419. doi: 10.3390/ijms10083400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Fessenden RJ, Fessenden JS. Organic chemistry. 6th ed. California: Brooks/Cole Publishing Inc; 1998. pp. 134–141. [Google Scholar]
- 4.Habbal OA, Al-Jabri AA, El-Hag A, Al-Mahrooqi ZH, Al-Hashmi NA. In vitro antimicrobial activity of Lawsonia inermis Linn (henna): a pilot study on the omani Henna. Saudi Med J. 2005;26:69–72. [PubMed] [Google Scholar]
- 5.Habbal OA, Al-Jabri AA, El-Hag AG. Antimicrobial properties of Lawsonia inermis (henna): a review. Aust J Med Herbal. 2007;19:114–125. [Google Scholar]
- 6.Ali NA, Julich WD, Kusnick C, Lindequist U. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J Ethnopharmacol. 2001;74:173–179. doi: 10.1016/s0378-8741(00)00364-0. [DOI] [PubMed] [Google Scholar]
- 7.Ali BH, Bashir AK, Tanira MO. Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats. Pharmacology. 1995;51:356–363. doi: 10.1159/000139347. [DOI] [PubMed] [Google Scholar]
- 8.Borade AS, Babasaheb NK, Shete RV. A phytopharmacological review on Lawsonia inermis (Linn.) Int J Pharm Life Sci. 2011;2(1):536–541. [Google Scholar]
- 9.Rahmatullah M, Mukti IJ, Haque AKM, Fahmidul MD, Mollik AH, Parvin K, et al. An ethnobotanical survey and pharmacological evaluation of medicinal plants used by the Garo Tribal Community living in Netrakona district, Bangladesh. Adv Nat Appl Sci. 2009;3(3):402–418. [Google Scholar]
- 10.Hema R, Kumaravel S, Gomathi S, Sivasubramaniam C. Gas chromatography-mass spectroscopic analysis of Lawsonia inermis leaves. New York Sci J. 2010;3(11):141–143. [Google Scholar]
- 11.Holder IA, Boyce ST. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns. 1994;20(5):426–429. doi: 10.1016/0305-4179(94)90035-3. [DOI] [PubMed] [Google Scholar]
- 12.Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, et al. International nosocomial infection control consortium report, data summary for 2002-2007, issued January. Am J Infect Control. 2008;36:627–637. doi: 10.1016/j.ajic.2008.03.003. [DOI] [PubMed] [Google Scholar]
- 13.De Sousa B, Russell P, Moir G. Henna skin reaction. Plast Reconstr Surg. 2003;111:2487–2488. doi: 10.1097/01.PRS.0000063135.57535.16. [DOI] [PubMed] [Google Scholar]
- 14.Suárez C, Peña C, Tubau F, Gavaldà L, Manzur A, Dominguez MA, et al. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections. J Infect. 2009;58:285–290. doi: 10.1016/j.jinf.2009.02.010. [DOI] [PubMed] [Google Scholar]
- 15.Nirmalan M, Baldwin J. Anaesthetic implications of henna. Eur J Anaesthesiol. 1997;14:665–666. doi: 10.1097/00003643-199711000-00021. [DOI] [PubMed] [Google Scholar]
- 16.Maekawa LE, Lamping R, Marcacci S, Maekawa MY, Nassri MRG, Koga-ITO CY. Antimicrobial activity of chlorophyll-based solution on Candida albicans and Enterococcus faecalis. Revista Sul-Brasileira de Odontologia. 2007;4(2):37–40. [Google Scholar]
- 17.Smith L. The present status of topical chlorophyll therapy. NY State J Med. 1955;55:2041–2050. [PubMed] [Google Scholar]
- 18.Scherer D, Kumar R. Genetics of pigmentation in skin cancer-a review. Mutat Res. 2010;705(2):141–153. doi: 10.1016/j.mrrev.2010.06.002. [DOI] [PubMed] [Google Scholar]
- 19.Thastrup O, Knudsen JB, Lemmich JL, Winther K. Inhibitions of human platelet aggregation by dihydropyrano- and dihydrofurano-coumarins, a new class of cAMP phosphodiesterase inhibitors. Biochem Pharmacol. 1985;34:2137–2140. doi: 10.1016/0006-2952(85)90407-1. [DOI] [PubMed] [Google Scholar]
- 20.Tan AS, Berridge MV. Differential effects of redox-cycling and arylating quinones on trans-plasma membrane electron transport. Biofactors. 2008;34(3):183–190. doi: 10.3233/BIO-2009-1071. [DOI] [PubMed] [Google Scholar]
- 21.Córdoba-Pedregosa MC, Villalba JM, González-Aragón D, Bello RI, Alcaín FJ. Cellular density and cell type are the key factors in growth inhibition induced by 2,5bis [1-aziridinyl]-1,4 benzoquinone (DZQ) Anticancer Res. 2006;(5A):3535–3540. [PubMed] [Google Scholar]